Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia

NCT03118128 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

102

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Metformin

Sponsor

Hospital General de Mexico